Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

NEW ORLEANS, Feb. 19, 2026 /PRNewswire/ -- TPN.health today announces it has surpassed 100,000 verified behavioral health providers on its platform across all 50 states, marking a major milestone that ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Start by thinking about the dilemmas your people will face. by Erin Meyer At the beginning of my career, I worked for the health-care-software specialist HBOC. One day, a woman from human resources ...

More than 12 years ago, Steam creator Valve attempted to usurp Microsoft's hold on PC gaming by introducing the first Steam Machine. The reliance on Linux and a loose hold on OEM hardware ...

Oscar Gonzalez is a Texas native who covered video games, conspiracy theories, misinformation and cryptocurrency. Valve dipped its toe into the hardware business when it released the Steam Deck ...

Vertex Pharmaceuticals is the leader in cystic fibrosis treatment. The company has also expanded into other areas in recent years, winning approval for two new drugs. 10 stocks we like better than ...

During the fourth quarter, the Harbor International Compounders ETF (Institutional Class, “ETF”) returned 3.80% (NAV), underperforming the benchmark, the MSCI All Country World ex-US Index, which ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Ed Silverman, a senior ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Novo Nordisk (CPSE:NOVO B) has used legal and regulatory pressure to push Hims & Hers to ...

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the United States’ top drug regulator has taken notice. “FDA will take swift action ...